Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,232 | -17,656 | -20,339 | -19,783 | -21,118 |
| Depreciation Amortization | 433 | 768 | 740 | 672 | 651 |
| Accounts receivable | -453 | -379 | 580 | -571 | -939 |
| Accounts payable and accrued liabilities | -163 | -1,332 | 393 | -245 | 1,868 |
| Other Working Capital | -738 | -2,878 | 2,594 | -1,079 | -1,130 |
| Other Operating Activity | 2,514 | 4,645 | -1,414 | 2,924 | 966 |
| Operating Cash Flow | $-6,639 | $-16,832 | $-17,446 | $-18,082 | $-19,702 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -141 | -393 | -617 | -873 | -475 |
| Purchase Of Investment | -43 | -31 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -4 | 56 |
| Investing Cash Flow | $-184 | $-424 | $-617 | $-877 | $-419 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -288 | N/A | N/A | 9,056 | 257 |
| Debt Repayment | 0 | -2,119 | -6,090 | -1,734 | -953 |
| Common Stock Issued | 11,378 | 2,514 | 21,939 | 21,957 | 298 |
| Other Financing Activity | -6 | -19 | 1,983 | 1,289 | 26,517 |
| Financing Cash Flow | $11,084 | $376 | $17,832 | $30,568 | $26,119 |
| Exchange Rate Effect | 76 | -22 | 4 | -7 | 144 |
| Beginning Cash Position | 1,921 | 18,823 | 19,050 | 7,448 | 3,287 |
| End Cash Position | 6,258 | 1,921 | 18,823 | 19,050 | 7,448 |
| Net Cash Flow | $4,337 | $-16,902 | $-227 | $11,602 | $4,161 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,639 | -16,832 | -17,446 | -18,082 | -19,702 |
| Capital Expenditure | -141 | -393 | -617 | -873 | -475 |
| Free Cash Flow | -6,780 | -17,225 | -18,063 | -18,955 | -20,177 |